Northern California Record

Wednesday, September 18, 2019

Amgen Inc.

Recent News About Amgen Inc.

  • Appeals court grants stay in antibody patent claim

    WASHINGTON (Northern California Record) -- The U.S. Court of Appeals for the Federal Circuit has stayed a Delaware court’s decision allowing for the continued sale of the cholesterol-fighting drug Praluent until the courts can render a final verdict in the manufacturers Sanofi and Regeneron’s legal battle with Amgen Inc.